biote Corp. (BTMD)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Long-term service agreements and sales of Biote-branded dietary supplements	192.22M	197.19M	185.36M	164.96M	139.40M
Long-term service agreements and sales of Biote-branded dietary supplements Growth	-2.52%	6.38%	12.37%	18.34%	19.58%
Total	192.22M	197.19M	185.36M	164.96M	139.40M
Total Growth	-2.52%	6.38%	12.37%	18.34%	19.58%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
United States	191.22M	196.17M	184.63M	164.52M	139.15M
United States Growth	-2.52%	6.25%	12.22%	18.24%	19.45%
ALL Other	1.00M	1.02M	735.00K	434.00K	249.00K
ALL Other Growth	-1.96%	38.78%	69.35%	74.30%	200.00%
Total	192.22M	197.19M	185.36M	164.96M	139.40M
Total Growth	-2.52%	6.38%	12.37%	18.34%	19.58%

Data Source: S&P Global Market Intelligence Last updated: Mar 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error